berberine has been researched along with fluorouracil in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (7.69) | 18.2507 |
2000's | 1 (7.69) | 29.6817 |
2010's | 5 (38.46) | 24.3611 |
2020's | 6 (46.15) | 2.80 |
Authors | Studies |
---|---|
Gao, F; Wang, T; Xiao, J; Zhang, X | 1 |
Hatanaka, T; Kadota, S; Katayama, K; Koizumi, T; Namba, T; Sekiya, K; Toshinal, A | 1 |
Fu, LC; Lü, GW; Lü, WB; Meng, GZ; Shen, JS; Song, ZF; Sun, DD; Ye, XM | 1 |
Cai, Y; Huang, P; Jiang, W; Luo, R; Shi, Y; Sun, Y; Xia, Q | 1 |
Dong, S; Qi, B; Qu, H; Tang, N; Tong, X; Wang, L; Yu, B; Yu, M; Zhang, C; Zhang, N | 1 |
Bharti, AC; Dwivedi, M; Mahata, S; Mehrotra, R; Misra, SP; Misra, V; Pandey, A; Tripathi, SC; Vishnoi, K | 1 |
Jin, DY; Lou, WH; Rong, YF; Wu, W; Xu, XF; Zhang, L | 1 |
Chen, H; Guo, Y; Li, R; Li, Y; Liu, Y; Wang, X; Xu, C; Yao, Q; Zhang, F; Zhang, X | 1 |
Abrams, SL; Akula, SM; Candido, S; Cervello, M; Cocco, L; Duda, P; Falzone, L; Gizak, A; Libra, M; Martelli, AM; McCubrey, JA; Meher, AK; Montalto, G; Rakus, D; Ratti, S; Ruvolo, P; Steelman, LS | 1 |
Al-Bagawi, AH; Fareid, MA; Habotta, OA; Moneim, AEA; Obeidat, ST; Othman, MS | 1 |
Ghasemi, F; Sahebkar, A; Ziasarabi, P | 1 |
Haeri, A; Kamalinejad, M; Mortazavi, SA; Rabbani, S; Vaezi, H | 1 |
He, J; Li, H; Sun, C; Tan, J; Wang, D; Wu, L; Xi, Y; Yan, M | 1 |
1 review(s) available for berberine and fluorouracil
Article | Year |
---|---|
Quinolone hybrids and their anti-cancer activities: An overview.
Topics: Animals; Antineoplastic Agents; Humans; Neoplasms; Quinolones; Structure-Activity Relationship | 2019 |
12 other study(ies) available for berberine and fluorouracil
Article | Year |
---|---|
[Study on baths with crude drug. II.: the effects of coptidis rhizoma extracts as skin permeation enhancer].
Topics: Animals; Baths; Berberine; Berberine Alkaloids; Drugs, Chinese Herbal; Fluorouracil; In Vitro Techniques; Male; Rats; Rats, Wistar; Skin Absorption; Solubility; Stimulation, Chemical; Water | 1995 |
[Study on the interaction of anticancer drugs and DNA using fluorescence spectroscopy].
Topics: Antineoplastic Agents; Berberine; DNA; Fluorouracil; Kinetics; Mitomycins; Reproducibility of Results; Spectrometry, Fluorescence | 2005 |
Berberine inhibits the growth of human colorectal adenocarcinoma in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Berberine; CDC2 Protein Kinase; cdc25 Phosphatases; Cell Proliferation; Colorectal Neoplasms; Cyclin B; Cyclin B1; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Fluorouracil; G2 Phase Cell Cycle Checkpoints; HT29 Cells; Humans; Inhibitory Concentration 50; Mice; Mice, Inbred BALB C; Mice, Nude; Time Factors; Xenograft Model Antitumor Assays | 2014 |
Berberine enhances chemosensitivity to irinotecan in colon cancer via inhibition of NF‑κB.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; bcl-X Protein; Berberine; Camptothecin; Colonic Neoplasms; Down-Regulation; Doxorubicin; Fluorouracil; HCT116 Cells; Humans; Inhibitor of Apoptosis Proteins; Irinotecan; NF-kappa B; RNA Interference; RNA, Small Interfering; Survivin; Transcription Factor RelA | 2014 |
Berberine and Curcumin Target Survivin and STAT3 in Gastric Cancer Cells and Synergize Actions of Standard Chemotherapeutic 5-Fluorouracil.
Topics: Berberine; Cell Line, Tumor; Cell Survival; Curcumin; DNA; Drug Resistance, Neoplasm; Drug Synergism; Fluorouracil; Humans; Inhibitor of Apoptosis Proteins; NF-kappa B; Quercetin; Signal Transduction; STAT3 Transcription Factor; Stomach Neoplasms; Survivin | 2015 |
SN38 increases IL-8 expression through the MAPK pathways in HCT8 cells.
Topics: Berberine; Camptothecin; Cell Line, Tumor; Cell Survival; Fluorouracil; Humans; Interleukin-8; Irinotecan; Janus Kinase 2; MAP Kinase Signaling System; Phosphorylation; Quinazolines; Up-Regulation | 2017 |
Berberine regulates fecal metabolites to ameliorate 5-fluorouracil induced intestinal mucositis through modulating gut microbiota.
Topics: Animals; Berberine; Cytokines; Fecal Microbiota Transplantation; Feces; Fluorouracil; Gastrointestinal Microbiome; Intestinal Mucosa; Intestines; Male; Rats, Sprague-Dawley | 2020 |
GSK-3β Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and Nutraceuticals.
Topics: Adenocarcinoma; Adenylate Kinase; Antineoplastic Agents; bcl-X Protein; Berberine; Biphenyl Compounds; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Diabetes Mellitus; Dietary Supplements; Disease Progression; Doxorubicin; Female; Fluorouracil; Gemcitabine; Glycogen Synthase Kinase 3 beta; Glycolysis; Humans; Inhibitory Concentration 50; Malaria; MCF-7 Cells; Metformin; Molecular Targeted Therapy; Neoplasm Metastasis; Nitrophenols; Pancreatic Neoplasms; Piperazines; Protein Kinase Inhibitors; Signal Transduction; Sulfonamides; Thiadiazoles; Tumor Stem Cell Assay | 2021 |
Antitumor Activity of Zinc Nanoparticles Synthesized with Berberine on Human Epithelial Colorectal Adenocarcinoma (Caco-2) Cells through Acting on Cox-2/NF-kB and p53 Pathways.
Topics: Adenocarcinoma; Animals; Apoptosis; bcl-2-Associated X Protein; Berberine; Caco-2 Cells; Caspase 3; Chlorocebus aethiops; Colorectal Neoplasms; Fluorouracil; Humans; Metal Nanoparticles; NF-kappa B; Tumor Suppressor Protein p53; Vero Cells; Zinc | 2022 |
Evaluation of the Effects of Nanomicellar Curcumin, Berberine, and Their Combination with 5-Fluorouracil on Breast Cancer Cells.
Topics: Apoptosis; Berberine; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Curcumin; Drug Synergism; Female; Fluorouracil; Humans | 2021 |
Fabrication, in Vitro, and in Vivo Characterization of Mucoadhesive Berberine-Loaded Blended Wafers for Treatment of Chemotherapy-Induced Oral Mucositis.
Topics: Alginates; Animals; Antineoplastic Agents; Berberine; Chitosan; Fluorouracil; Hypromellose Derivatives; Rats; Spectroscopy, Fourier Transform Infrared; Stomatitis | 2022 |
Berberine-Based Carbon Quantum Dots Improve Intestinal Barrier Injury and Alleviate Oxidative Stress in C57BL/6 Mice with 5-Fluorouracil-Induced Intestinal Mucositis by Enhancing Gut-Derived Short-Chain Fatty Acids Contents.
Topics: Animals; Berberine; Fatty Acids, Volatile; Fluorouracil; Intestinal Diseases; Intestinal Mucosa; Mice; Mice, Inbred C57BL; Mucositis; Occludin; Oxidative Stress; Quantum Dots | 2023 |